Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2014177676) FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2014/177676 International Application No.: PCT/EP2014/058954
Publication Date: 06.11.2014 International Filing Date: 01.05.2014
IPC:
A61K 31/137 (2006.01) ,A61K 45/06 (2006.01) ,A61P 25/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
137
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
08
Antiepileptics; Anticonvulsants
Applicants:
KATHOLIEKE UNIVERSITEIT LEUVEN [BE/BE]; KU Leuven Research & Development Waaistraat 6 - Box 5101 B-3000 Leuven, BE
UNIVERSITY HOSPITAL ANTWERP [BE/BE]; Wilrijkstraat 10 B-2650 Edegem, BE
Inventors:
CEULEMANS, Berten; BE
LAGAE, Lieven; BE
Agent:
FERRAR, Nicholas; Adamson Jones BioCity Nottingham Pennyfoot Street Nottingham Nottinghamshire NG1 1GF, GB
Priority Data:
13/887,01403.05.2013US
Title (EN) FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME
(FR) FENFLURAMINE DESTINÉE À ÊTRE UTILISÉE POUR LE TRAITEMENT DU SYNDROME DE DRAVET
Abstract:
(EN) An effective dose of fenfluramine or its pharmaceutically acceptable salt for use in a method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome.
(FR) L'invention concerne une dose efficace de fenfluramine, ou de son sel pharmaceutiquement acceptable, destinée à être utilisée dans une méthode de traitement et/ou de prévention du syndrome de Dravet chez un patient, tel qu'un patient précédemment diagnostiqué avec le syndrome de Dravet.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CA2909335EP2991637AU2014261329BR112015027282DK2991637ES2666657
EP3329909PT2991637